Top Tissue Banking Companies

The competitive landscape of the global tissue banking market outlook is dynamic, with key players focused on expanding their biobanking capabilities. Prominent companies include Thermo Fisher Scientific, BioCision, and Lonza Group. These companies emphasize technological innovation, strategic acquisitions, and partnerships. For example, Thermo Fisher has focused on expanding its cryopreservation technology portfolio, while Lonza Group invests in cell-based therapies and collaborations to strengthen its position in tissue preservation and regenerative medicine applications.

The startup landscape of the global tissue banking market is rapidly growing, with innovative companies focused on improving tissue preservation, biobanking technologies, and regenerative medicine applications. Startups in this space are leveraging advancements in cryopreservation, automation, and AI-driven diagnostics to enhance tissue storage, increase accessibility, and support medical research, providing significant opportunities for growth and innovation in biobanking services globally.

• Founded in 2016, Tissue Analytics is focused on AI-driven tissue analysis for diagnostic and research purposes. Their flagship product, the "Tissue Analytics Imaging Platform," uses machine learning to automate tissue sample analysis, enhancing accuracy and speed. The breakthrough innovation lies in integrating AI with tissue imaging, allowing tissue banks and researchers to better assess tissue quality, improve sample handling, and streamline biobanking processes.

• Established in 2015, CryoVivo specializes in cryogenic storage solutions for the preservation of biological materials, including tissues, cells, and organs. One of its key offerings is the "CryoVivo Biobank," which utilizes state-of-the-art cryopreservation technology to ensure the long-term viability of biological samples. A breakthrough innovation by CryoVivo is its proprietary cryopreservation technology that allows for more efficient and reliable tissue storage.

Top Player’s Company Profiles

• Thermo Fisher Scientific (USA)

• Lonza Group (Switzerland)

• BioCision (USA)

• Stemcell Technologies (Canada)

• VWR International (USA)

• Cryoport, Inc. (USA)

• Bio-Techne Corporation (USA)

• Promega Corporation (USA)

• Charles River Laboratories (USA)

• Tecan Group (Switzerland)

• Labcorp Drug Development (USA)

• Merck KGaA (Germany)

• Miltenyi Biotec (Germany)

• Sartorius AG (Germany)

• Biolife Solutions (USA)

Recent Developmentsin Tissue Banking Market

• In April 2025, Thermo Fisher Scientific launched an advanced cryopreservation system, the CryoCube™ Series, specifically designed for tissue banking applications. This innovation enhances the storage and viability of biological samples by offering precise temperature control and automation, ensuring the preservation quality of sensitive tissues for regenerative medicine research and clinical use.

• In March 2025, Lonza Group announced a significant upgrade to its cell therapy manufacturing platform. The company introduced new cryopreservation protocols, which are optimized for preserving stem cells and tissues. This breakthrough is expected to enhance the efficiency of biobanks in delivering high-quality samples for clinical applications, expanding access to regenerative treatments.

• In February 2025, BioCision unveiled its new automated tissue storage system, the CryoStor™-XT. This system provides a reliable, automated solution for tissue banking facilities to store and manage cryopreserved biological materials. The development improves sample integrity and simplifies the workflow, ensuring a higher standard of tissue preservation for research and clinical applications.